Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse - TIPA

NCT02686918 is registered in ClinicalTrials.gov with Institut de Cancérologie de la Loire as lead sponsor.

NCT NCT02686918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02686918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse - TIPA
Lead sponsor
Institut de Cancérologie de la Loire
Phase
Not applicable
Overall status
Unknown status
Start date
February 29, 2016
Completion date
December 31, 2017
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms